IP Library Granted Patent US 9,387,042
Granted Patent B2
US 9,387,042 · App. 13/932,725 · Granted Jul 12, 2016

Hyperthermia treatment and probe therefor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,387,042
App. No.
13/932,725
Granted
Jul 12, 2016
Kind
B2
Abstract

In vivo hyperthermia treatment of a target tissue can include imaging the target tissue with a magnetic resonance imaging (MRI) system, positioning a hyperthermia treatment probe in or proximate to the target tissue based on the imaging, and heating the target tissue by the probe. During the heating, changes in temperature of a volume of tissue that includes the target tissue can be monitored with the MRI system to determine an amount of the heating applied to the target tissue, and the heating can be terminated when the amount of the heating reaches a predetermined amount.

Claims (28)

1. A method of in vivo hyperthermia treatment of a targeted area of brain target tissue, the method comprising:

imaging the brain target tissue with a magnetic resonance imaging (MRI) system;

positioning a hyperthermia treatment probe in or proximate to the targeted area of the brain target tissue based on the imaging;

operating a power output source, by a device controller, to heat the targeted area of the brain target tissue with the hyperthermia treatment probe;

monitoring, by the device controller during the heating, changes in temperature in real time of a volume of tissue that includes the targeted area of the brain target tissue to determine an amount of the heating applied to the targeted area of the brain target tissue, wherein monitoring comprises receiving information from the MRI system indicative of temperatures, and determining changes in temperature in both the targeted area and a portion of surrounding non-target tissue;

during monitoring,

identifying, by the device controller, a difference between a penetration depth of the heating and a boundary of the targeted area,

adjusting, by the device controller responsive to identifying the difference between the penetration depth and the boundary, the power output source of the hyperthermia treatment probe, and

identifying, by the device controller, the amount of the heating in the targeted area has reached a predetermined amount; and

terminating, by the device controller responsive to identifying the amount of the heating in the targeted area has reached the predetermined amount, the power output source.

2. The method according to claim 1 , further comprising:

injecting a cooling fluid into the hyperthermia treatment probe to control at least one of a) an amount of heating of the hyperthermia treatment probe or b) the amount of the heating applied to the targeted area of the brain target tissue.

3. The method according to claim 2 , wherein

the injecting includes controlling an amount of cooling provided by the cooling fluid based on the monitoring.

4. The method according to claim 3 , wherein controlling an amount of cooling provided by the cooling fluid based on the monitoring comprises controlling, by the device controller, a fluid pressure delivered from a pressurized supply of cooling fluid.

5. The method according to claim 1 , further comprising:

after the terminating, repositioning the probe to a new position to perform heating of an additional targeted area of the brain target tissue based on imaging of the additional target area of the brain target tissue.

6. The method according to claim 1 , wherein the hyperthermia treatment probe includes a fiber to emit heat energy in the form of light from an external laser source.

7. The method according to claim 6 , wherein the hyperthermia treatment probe includes a cooling fluid inlet and a cooling fluid outlet, the method further comprising:

injecting, during the monitoring, a cooling fluid into the cooling fluid inlet to control or limit at least one of a) an amount of heating of the hyperthermia treatment probe or b) the amount of the heating applied to the targeted area of the brain target tissue; and

outputting the cooling fluid from the cooling fluid outlet.

8. The method according to claim 7 , wherein the injecting the cooling fluid causes the cooling fluid to contact a heat energy-emitting portion of the fiber.

9. The method according to claim 8 , wherein:

the hyperthermia treatment probe has a longitudinal axis; and

the hyperthermia treatment probe is configured to emit heat energy in the form of light in a limited angular region in a direction that is substantially lateral to the longitudinal axis.

10. The method according to claim 7 , further comprising controlling, by the device controller, a flow of the cooling fluid based on the monitoring.

11. The method according to claim 1 , wherein adjusting the power output source comprises varying at least one of a pulse rate and a power level of the power output source.

12. The method according to claim 1 , wherein the power output source is a laser source.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 11, 2026
From: TRINITY CAPITAL INC.
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 075615/0671 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2026
From: MADRYN HEALTH PARTNERS, LP
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 073999/0803 →
SECURITY INTEREST Recorded Sep 7, 2022
From: MONTERIS MEDICAL CORPORATION
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 061015/0673 →
RELEASE OF SECURITY INTEREST Recorded Sep 6, 2022
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: MONTERIS MEDICAL CORPORATION
Reel/Frame 061000/0405 →
SECURITY AGREEMENT Recorded Mar 7, 2019
From: MONTERIS MEDICAL CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 048528/0896 →